Amgen’s Bone Drug Gets Final Approval From UK Cost Agency

Amgen Inc.’s bone-strengthening drug Prolia should be provided to women at risk of fractures who can’t take existing drugs, said a UK agency that advises the state-run National Health Service on cost-effective treatments.
San Francisco Chronicle